The European Union Radiation, Education, Staffing & Training (EU-REST) study is a 24-month, European Commission-funded study, managed by the European Health and Digital Executive Agency (HaDEA), and was awarded to a consortium led by the European Society of Radiology (ESR) and consisting of the ESR, European Federation of Organisations for Medical Physics (EFOMP), European Federation of Radiographer Societies (EFRS), and European Society for Radiotherapy and Oncology (ESTRO) (with input from other stakeholders, including the European Association of Nuclear Medicine, EANM).
The study aims to provide an analysis of workforce availability, education, and training needs to ensure quality and safety aspects of medical applications involving ionising radiation in the EU. The study will seek to address the needs for a highly-qualified workforce and proper forecasts of staff requirements by collecting, analysing, and making widely available up-to-date data on staffing, education, and training of the key professional groups in EU Member States. The work will cover the areas of radiology, radiotherapy, nuclear medicine, and other medical practices utilising ionising radiation, as well as the main categories of staff falling under the Council Directive 2013/59/Euratom7 (‘Basic Safety Standards Directive’, BSSD) definitions of ‘Practitioner’, ‘Medical Physics Expert’, and staff carrying ‘practical aspects of medical radiological procedures’. The study also foresees the development of staffing and education/training guidelines for key professional groups involved in ensuring radiation safety and quality of medical radiation applications in the EU Member States.
The EU-REST study is part of the EU4Health 2021 Work Programme and will contribute to the implementation of Europe’s Beating Cancer Plan, as well as forming part of the actions of the Strategic Agenda for Medical Ionising Radiation Applications (SAMIRA) Action Plan in the area of Quality and Safety of medical applications of ionising radiation.
Work on the study began in September 2022. The study is scheduled to run for 2 years. More information to come soon!